Nuvectis Pharma (NVCT) closed at $21.08 on November 10, 2026, up 0.3% from the previous close, on volume of 195,989 shares (30-day average 191,146).
Data as of November 10, 2026.
10-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 16, 2026 | Call Spread | 20-Nov-2617.5 : 20 C | 1,000 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 9, 2026. See the 10 largest for 30, 60 and 90 days
Nuvectis Pharma Reports Third Quarter 2026 Financial Results and Business Highlights
Globe Newswire (Wed, 4-Nov 7:00 AM ET)
Nuvectis Pharma to Report Third Quarter 2026 Financial Results on November 4, 2026
Globe Newswire (Mon, 2-Nov 5:00 PM ET)
Market Chameleon (Mon, 26-Oct 7:41 AM ET)
Globe Newswire (Mon, 26-Oct 8:30 AM ET)
Nuvectis Pharma to Participate in the Maxim Growth Summit 2026
Globe Newswire (Fri, 9-Oct 8:00 AM ET)
Globe Newswire (Thu, 24-Sep 8:00 AM ET)
Nuvectis Pharma To Participate in Upcoming Investor Conferences
Globe Newswire (Thu, 3-Sep 8:00 AM ET)
Market Chameleon (Tue, 4-Aug 5:19 AM ET)
Nuvectis Pharma Raises $100 Million to Accelerate Pipeline—NXP100, NXP900, and NXP200 in Focus
Market Chameleon (Tue, 30-Jun 3:05 AM ET)
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Nuvectis Pharma trades on the NASDAQ stock market under the symbol NVCT.
As of November 10, 2026, NVCT stock price climbed to $21.08 with 195,989 million shares trading.
NVCT has a beta of -1.12, meaning it tends to be less sensitive to market movements. NVCT has a correlation of 0.02 to the broad based SPY ETF.
NVCT has a market cap of $688.14 million. This is considered a Small Cap stock.
In the last 3 years, NVCT traded as high as $29.28 and as low as $4.44.
The top ETF exchange traded funds that NVCT belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
NVCT has outperformed the market in the last year with a price return of +243.3% while the SPY ETF gained +12.9%. NVCT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +11.2% and +14.0%, respectively, while the SPY returned -2.8% and -2.0%, respectively.
NVCT support price is $19.86 and resistance is $22.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVCT shares will trade within this expected range on the day.
